The importance of robust, integrated, and secure CQV services in all industries, emphasizing pharmaceuticals.
In the past three years, the global manufacturing process scale-up to support the COVID-19 vaccine development led to a complete transformation of best manufacturing practices across all industries.
In this podcast, CAI's Director of UK Operations Zagros Barazenda shares the best practices in operational readiness from his experience consulting in cGMP Biomedical, laboratory, and Biotechnological environments. Most recently, he facilitated the relationship between a global-leading COVID-19 vaccine developer and a brand manufacturing facility site to complete a typically 3-5 year project in one year.
Shifting from a chronological to an integrated approach – where quality assurance, automation, and engineering professionals are present in every phase – can help your production facility improve efficiency and ensure a seamless path to market.
Topics include:
- How a risk-based approach in the discovery phase can reduce deviations throughout the project's lifecycle
- How COVID-19 is changing manufacturing processes and operations – through the evolving workplace, adopting automation and AI, and new compliance standards
- How big players in the pharmaceutical industry are now outsourcing to CMOs
- The tell-signs a facility is not meeting government audit regulatory and compliance standards
